JP7727970B2 - 結腸直腸癌および／またはその前癌段階の診断またはスクリーニングのための非侵襲的方法 - Google Patents

結腸直腸癌および／またはその前癌段階の診断またはスクリーニングのための非侵襲的方法

Info

Publication number
JP7727970B2
JP7727970B2 JP2022502110A JP2022502110A JP7727970B2 JP 7727970 B2 JP7727970 B2 JP 7727970B2 JP 2022502110 A JP2022502110 A JP 2022502110A JP 2022502110 A JP2022502110 A JP 2022502110A JP 7727970 B2 JP7727970 B2 JP 7727970B2
Authority
JP
Japan
Prior art keywords
mir
colorectal cancer
mirna
screening
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2022502110A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541169A5 (https=
JP2022541169A (ja
Inventor
ガランゴウ，アントニ カステル
コス，メリチェル ヒロネーリャ
サライ デュラン，サンチョン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Original Assignee
Institut d'Investigacions Biomèdiques August Pi i Sunyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut d'Investigacions Biomèdiques August Pi i Sunyer filed Critical Institut d'Investigacions Biomèdiques August Pi i Sunyer
Publication of JP2022541169A publication Critical patent/JP2022541169A/ja
Publication of JP2022541169A5 publication Critical patent/JP2022541169A5/ja
Application granted granted Critical
Publication of JP7727970B2 publication Critical patent/JP7727970B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
JP2022502110A 2019-07-15 2020-07-14 結腸直腸癌および／またはその前癌段階の診断またはスクリーニングのための非侵襲的方法 Active JP7727970B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP19382597 2019-07-15
EP19382597.3 2019-07-15
PCT/EP2020/069918 WO2021009184A1 (en) 2019-07-15 2020-07-14 Non-invasive method for the diagnosis or screening of colorectal cancer and/or pre-cancerous stage thereof

Publications (3)

Publication Number Publication Date
JP2022541169A JP2022541169A (ja) 2022-09-22
JP2022541169A5 JP2022541169A5 (https=) 2023-07-24
JP7727970B2 true JP7727970B2 (ja) 2025-08-22

Family

ID=67480120

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022502110A Active JP7727970B2 (ja) 2019-07-15 2020-07-14 結腸直腸癌および／またはその前癌段階の診断またはスクリーニングのための非侵襲的方法

Country Status (5)

Country Link
US (1) US20220333205A1 (https=)
EP (1) EP3999663A1 (https=)
JP (1) JP7727970B2 (https=)
AU (1) AU2020315134A1 (https=)
WO (1) WO2021009184A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4130296A1 (en) * 2021-08-03 2023-02-08 Deutsches Krebsforschungszentrum - Stiftung des öffentlichen Rechts / Universität Heidelberg Cancer prediction
CN114107514A (zh) * 2022-01-27 2022-03-01 天津欧德莱生物医药科技有限公司 一种用于结直肠癌诊断的miRNA分子标志物及其试剂盒
CN116219019B (zh) * 2023-03-02 2026-01-27 圣湘生物科技股份有限公司 一种用于结直肠癌诊断的microRNA标志物组合物及检测试剂、检测试剂盒

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010533855A (ja) 2007-07-19 2010-10-28 ビオメリュー 結腸直腸癌のインビトロ診断のためのアポリポタンパク質ａｉｉ・アッセイ方法
US20110281756A1 (en) 2008-11-13 2011-11-17 Ying Wu Compositions and methods for micro-rna expression profiling of colorectal cancer
US20120088687A1 (en) 2010-10-08 2012-04-12 Baylor Research Institute MicroRNAs (miRNA) as Biomarkers for the Identification of Familial and Non-Familial Colorectal Cancer
US20130029874A1 (en) 2008-03-06 2013-01-31 Elizabeth Mambo Microrna markers for recurrence of colorectal cancer
JP2014530619A (ja) 2011-10-21 2014-11-20 ホスピタル クリニク デ バルセロナ 早期結腸直腸癌の検出のための血漿マイクロｒｎａ

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL418144A1 (pl) * 2016-07-29 2018-02-12 Gdański Uniwersytet Medyczny Nowy marker obecności mikroprzerzutów i podwyższonego ryzyka nawrotu raka jelita grubego, sposób wykrywania obecności mikroprzerzutów i podwyższonego ryzyka nawrotu raka jelita grubego oraz geny normalizacyjne do normalizacji wyników ekspresji miRNA w tkance raka jelita grubego

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2010533855A (ja) 2007-07-19 2010-10-28 ビオメリュー 結腸直腸癌のインビトロ診断のためのアポリポタンパク質ａｉｉ・アッセイ方法
US20130029874A1 (en) 2008-03-06 2013-01-31 Elizabeth Mambo Microrna markers for recurrence of colorectal cancer
US20110281756A1 (en) 2008-11-13 2011-11-17 Ying Wu Compositions and methods for micro-rna expression profiling of colorectal cancer
US20120088687A1 (en) 2010-10-08 2012-04-12 Baylor Research Institute MicroRNAs (miRNA) as Biomarkers for the Identification of Familial and Non-Familial Colorectal Cancer
JP2014530619A (ja) 2011-10-21 2014-11-20 ホスピタル クリニク デ バルセロナ 早期結腸直腸癌の検出のための血漿マイクロｒｎａ

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LI, Y et al.，Upregulated expression of miR-421 is associated with poor prognosis in non-small-cell lung cancer，Cancer Management and Research，2018年，Vol. 10，pp. 2627-2633

Also Published As

Publication number Publication date
AU2020315134A1 (en) 2022-02-03
US20220333205A1 (en) 2022-10-20
WO2021009184A1 (en) 2021-01-21
EP3999663A1 (en) 2022-05-25
JP2022541169A (ja) 2022-09-22

Similar Documents

Publication Publication Date Title
Duran-Sanchon et al. Identification and validation of microRNA profiles in fecal samples for detection of colorectal cancer
WO2019068082A1 (en) Dna methylation biomarkers for cancer diagnosing
JP2025114665A (ja) 胃がんを診断するためのｍｉＲＮＡマーカーの組み合わせ物、およびキット
CN103937888B (zh) 鉴别胃癌的血浆microRNA标志物的筛选与应用
JP7727970B2 (ja) 結腸直腸癌および／またはその前癌段階の診断またはスクリーニングのための非侵襲的方法
CN108300787A (zh) 特异甲基化位点作为乳腺癌早期诊断标志物的应用
ES3032051T3 (en) A method for diagnosing endometrial or ovarian carcinoma
CN116144782A (zh) 一种用于肺癌检测的组合标志物及其应用
CN104630357A (zh) 一种与结直肠癌相关的血浆miRNA生物标志物及其应用
CN114457160A (zh) miRNA分子作为早期肺癌检测标志物的应用
EP4189119A1 (en) Biomarkers for diagnosing and monitoring lung cancer
CN116083579B (zh) 用于非小细胞肺癌诊断的circRNA-miRNA-mRNA调控网络及其应用
US20240093306A1 (en) Micro rna liver cancer markers and uses thereof
US20220220562A1 (en) In vitro method for identifying colorectal adenomas or colorectal cancer
CN119741967A (zh) 一种基于cfDNA差异统计的癌症早筛模型的构建方法及装置
CN117413071A (zh) 制备用于癌症诊断的多分析预测模型的方法
CN108531593A (zh) 特异甲基化位点作为乳腺癌复发诊断标志物的应用
CN114875151B (zh) 血浆外泌体生物标志物在胃癌新辅助化疗敏感人群筛查或疗效预测中的应用
CN114402082B (zh) 用于结直肠癌或其癌前阶段的诊断或预后的体外方法
RU2831090C2 (ru) Способ in vitro диагностики или прогнозирования колоректального рака или его предраковой стадии
Zhao et al. Evaluating the performance of a plasma dual-target test developed based on sense-antisense and dual-MGB probe technique for colorectal cancer detection
WO2026090778A1 (zh) 用于检测胃癌的标志物、试剂盒及其应用
CN116219007A (zh) 检测结直肠癌的生物标志物组及其应用
Gallardo-Gómez et al. Highly-specific early detection of colorectal cancer by novel non-invasive serum methylation biomarkers
EP4526473A2 (en) Biomarkers for colorectal neoplasia

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230713

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230713

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240702

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240930

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241210

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250228

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20250508

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250604

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250708

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250801

R150 Certificate of patent or registration of utility model

Ref document number: 7727970

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150